US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

41.07

-0.1700-0.41%

Pre-market: 41.070.00000.00%09:20 EDT

Volume:2.26M

Turnover:93.02M

Market Cap:10.67B

PE:14.77

High:41.64

Open:41.60

Low:40.97

Close:41.24

52wk High:49.62

52wk Low:32.38

Shares:259.71M

Float Shares:223.00M

Volume Ratio:0.78

T/O Rate:1.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.78

EPS(LYR):2.78

ROE:35.53%

ROA:19.27%

PB:4.94

PE(LYR):14.77

Loading ...

Overview Company News Filings

Earning Preview: Exelixis Q4 revenue is expected to increase by 7.19%, and institutional views are mostly positive

Exelixis Is Maintained at Equal-Weight by Morgan Stanley

Exelixis reports zanzalintinib new drug application accepted for review by FDA

FDA Accepts Exelixis Application for Zanzalintinib Combination in Metastatic Colorectal Cancer

Exelixis Inc - FDA Sets Pdufa Target Action Date for December 3, 2026

THOMSON REUTERS

Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination With an Immune Checkpoint Inhibitor for Patients With Metastatic Colorectal Cancer

THOMSON REUTERS

Morgan Stanley Lifts Price Target on Exelixis to $49 From $48, Keeps Overweight Rating

MT Newswires Live

Exelixis Inc. to Release Fourth Quarter and Fiscal Year 2025 Financial Results

Exelixis Is Maintained at Buy by HC Wainwright & Co.

Exelixis price target raised to $52 from $49 at H.C. Wainwright

Assessing Exelixis (EXEL) Valuation After Recent Share Price Pullback And Long Term Gains

Simply Wall St.

Truist Securities Adjusts Price Target on Exelixis to $51 From $49, Maintains Buy Rating

MT Newswires Live

Does Exelixis’ 2026 Revenue Guidance and Zanzalintinib Push Change The Bull Case For EXEL?

Simply Wall St.

Exelixis Projects 2026 Net Product Revenues of $2.325 Billion to $2.425 Billion

Exelixis, Citigroup And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Benzinga_recent_news

Press Release: Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026

Barclays Remains a Hold on Exelixis (EXEL)

Exelixis reports preliminary FY25 revenue $2.32B, consensus $2.33B

Exelixis sees FY26 revenue $2.525B-$2.625B, consensus $2.62B

BRIEF-Exelixis Says Fiscal Year 2026 Net Product Revenues Guidance Of $2.325 Billion - $2.425 Billion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EXEL/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EXEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","market":"US","secType":"STK","nameCN":"Exelixis","latestPrice":41.07,"timestamp":1773691200000,"preClose":41.24,"halted":0,"volume":2258904,"hourTrading":{"tag":"盘前","latestPrice":41.07,"preClose":41.07,"latestTime":"09:20 EDT","volume":1374,"amount":56412.590052,"timestamp":1773753638359,"change":0,"changeRate":0,"amplitude":0.034575},"delay":0,"changeRate":-0.0041222114451988775,"floatShares":223000000,"shares":259708689,"eps":2.78,"marketStatus":"Pre-Mkt","change":-0.17,"latestTime":"03-17 09:28:37 EDT","open":41.6,"high":41.635,"low":40.97,"amount":93022305.98983201,"amplitude":0.016125,"askPrice":41.74,"askSize":132,"bidPrice":41.01,"bidSize":450,"shortable":3,"etf":0,"ttmEps":2.78,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773754200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":955425600000,"exchange":"NASDAQ","adjPreClose":41.07,"preHourTrading":{"tag":"盘前","latestPrice":41.07,"preClose":41.07,"latestTime":"09:20 EDT","volume":1374,"amount":56412.590052,"timestamp":1773753638359,"change":0,"changeRate":0,"amplitude":0.034575},"postHourTrading":{"tag":"盘后","latestPrice":41.07,"preClose":41.07,"latestTime":"18:21 EDT","volume":39152,"amount":1607973.12,"timestamp":1773699688071,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7766772577227816,"impliedVol":0.2784,"impliedVolPercentile":0.128},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","floatShares":223000000,"roa":"19.27%","roe":"35.53%","lyrEps":2.78,"volumeRatio":0.7766772577227816,"shares":259708689,"dividePrice":0,"high":41.635,"amplitude":0.016125,"preClose":41.24,"low":40.97,"week52Low":32.38,"pbRate":"4.94","psRate":"4.60","week52High":49.62,"institutionHeld":0.8369,"latestPrice":41.07,"committee":0.546392,"eps":2.78,"divideRate":0,"volume":2258904,"delay":0,"ttmEps":2.78,"open":41.6,"prevYearClose":43.83,"fiveDayClose":42.37,"twentyDayClose":43.92,"sixtyDayClose":41.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EXEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-10","symbol":"EXEL","fiscalQuarterEnding":"2025/12","expectedEps":0.68,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2026-01-11","symbol":"EXEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1768107600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"EXEL","fiscalQuarterEnding":"2025/09","expectedEps":0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.67},{"market":"US","date":"2025-07-28","symbol":"EXEL","fiscalQuarterEnding":"2025/06","expectedEps":0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753675200000,"reportTimeType":"post","actualEps":0.65},{"market":"US","date":"2025-05-13","symbol":"EXEL","fiscalQuarterEnding":"2025/03","expectedEps":0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":0.53}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EXEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EXEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1905,"buy":0.2857,"hold":0.4762,"sell":0.0476,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":21,"updateTime":1768104000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EXEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EXEL","date":"2026-03-16","current":14.773381,"percent":0.002431,"low":13.520237,"twenty":18.397459,"median":29.434352,"eighty":42.231595,"high":123.671097,"avg":35.212698,"sd":22.845362,"marketCap":10710386334},"quantilePoints":[{"date":"2021-03-19","current":65.311261,"twenty":-27.329077,"median":9.710451,"eighty":25.161223,"marketCap":7300558067},{"date":"2021-03-26","current":63.329595,"twenty":-27.325861,"median":9.736947,"eighty":25.234082,"marketCap":7079045408},{"date":"2021-04-01","current":64.529759,"twenty":-27.325861,"median":9.747742,"eighty":25.270502,"marketCap":7213200962},{"date":"2021-04-09","current":64.529759,"twenty":-27.329077,"median":9.805299,"eighty":25.357929,"marketCap":7213200962},{"date":"2021-04-16","current":66.075436,"twenty":-27.329077,"median":9.834498,"eighty":25.412148,"marketCap":7385978281},{"date":"2021-04-23","current":69.268568,"twenty":-27.329077,"median":9.92067,"eighty":25.491815,"marketCap":7742909830},{"date":"2021-04-30","current":68.960459,"twenty":-27.329077,"median":9.944579,"eighty":25.677015,"marketCap":7708469067},{"date":"2021-05-07","current":121.493789,"twenty":-27.329077,"median":9.977077,"eighty":25.790166,"marketCap":7869152717},{"date":"2021-05-14","current":123.671097,"twenty":-27.329077,"median":10.042797,"eighty":25.900353,"marketCap":8010176959},{"date":"2021-05-21","current":118.348789,"twenty":-27.329077,"median":10.090291,"eighty":26.029567,"marketCap":7665451034},{"date":"2021-05-28","current":109.107325,"twenty":-27.329077,"median":10.142137,"eighty":26.116578,"marketCap":7066881472},{"date":"2021-06-04","current":108.236402,"twenty":-27.329077,"median":10.259913,"eighty":26.305665,"marketCap":7010471775},{"date":"2021-06-11","current":111.187864,"twenty":-27.329077,"median":10.30588,"eighty":26.528137,"marketCap":7201637970},{"date":"2021-06-18","current":108.429941,"twenty":-27.329077,"median":10.499122,"eighty":26.899667,"marketCap":7023007264},{"date":"2021-06-25","current":113.316788,"twenty":-27.329077,"median":10.577409,"eighty":27.427848,"marketCap":7339528341},{"date":"2021-07-02","current":88.350322,"twenty":-27.329077,"median":10.668743,"eighty":28.437015,"marketCap":5722450363},{"date":"2021-07-09","current":87.140707,"twenty":-27.329077,"median":10.768777,"eighty":32.735526,"marketCap":5644103562},{"date":"2021-07-16","current":81.286167,"twenty":-27.329077,"median":12.586346,"eighty":38.333898,"marketCap":5264905044},{"date":"2021-07-23","current":80.947475,"twenty":-27.329077,"median":13.259462,"eighty":38.843712,"marketCap":5242967939},{"date":"2021-07-30","current":81.52809,"twenty":-27.329077,"median":13.665176,"eighty":39.250255,"marketCap":5280574404},{"date":"2021-08-06","current":57.789598,"twenty":-27.329077,"median":14.041856,"eighty":39.491398,"marketCap":5434591593},{"date":"2021-08-13","current":61.240223,"twenty":-27.329077,"median":14.246084,"eighty":40.05544,"marketCap":5759091844},{"date":"2021-08-20","current":61.776243,"twenty":-27.329077,"median":14.431907,"eighty":40.44398,"marketCap":5809499650},{"date":"2021-08-27","current":65.092863,"twenty":-27.329077,"median":14.633356,"eighty":40.76874,"marketCap":6121397950},{"date":"2021-09-03","current":66.231905,"twenty":-27.329077,"median":14.930088,"eighty":41.024831,"marketCap":6228514538},{"date":"2021-09-10","current":66.868428,"twenty":-27.329077,"median":15.002715,"eighty":41.184268,"marketCap":6288373808},{"date":"2021-09-17","current":69.41452,"twenty":-27.329077,"median":15.270884,"eighty":41.645802,"marketCap":6527810887},{"date":"2021-09-24","current":68.174975,"twenty":-27.329077,"median":15.454005,"eighty":42.220717,"marketCap":6411242835},{"date":"2021-10-01","current":72.16162,"twenty":-27.329077,"median":15.627908,"eighty":42.663031,"marketCap":6786150893},{"date":"2021-10-08","current":72.42963,"twenty":-27.329077,"median":15.773963,"eighty":43.366777,"marketCap":6811354796},{"date":"2021-10-15","current":73.099654,"twenty":-27.329077,"median":15.952475,"eighty":44.822559,"marketCap":6874364554},{"date":"2021-10-22","current":71.692603,"twenty":-27.329077,"median":16.00116,"eighty":45.312226,"marketCap":6742044063},{"date":"2021-10-29","current":72.061116,"twenty":-27.329077,"median":16.265432,"eighty":45.826118,"marketCap":6776699429},{"date":"2021-11-05","current":37.285528,"twenty":-27.329077,"median":16.391679,"eighty":45.919924,"marketCap":6125452889},{"date":"2021-11-12","current":34.858887,"twenty":-27.329077,"median":16.479897,"eighty":45.919924,"marketCap":5726792216},{"date":"2021-11-19","current":34.724073,"twenty":-27.329077,"median":16.682751,"eighty":45.919924,"marketCap":5704644400},{"date":"2021-11-26","current":32.855945,"twenty":-27.200425,"median":16.81027,"eighty":45.919924,"marketCap":5397738961},{"date":"2021-12-03","current":30.506341,"twenty":-26.943119,"median":16.933764,"eighty":45.919924,"marketCap":5011734182},{"date":"2021-12-10","current":32.066324,"twenty":-26.245177,"median":17.104522,"eighty":45.919924,"marketCap":5268016044},{"date":"2021-12-17","current":35.051477,"twenty":-24.694911,"median":17.218287,"eighty":45.919924,"marketCap":5758431952},{"date":"2021-12-23","current":37.131455,"twenty":-24.254275,"median":17.32582,"eighty":45.919924,"marketCap":6100141100},{"date":"2021-12-31","current":35.20555,"twenty":7.517288,"median":17.464132,"eighty":45.919924,"marketCap":5783743740},{"date":"2022-01-07","current":36.091466,"twenty":7.709485,"median":17.687208,"eighty":45.891374,"marketCap":5929286526},{"date":"2022-01-14","current":34.897405,"twenty":7.799575,"median":17.756166,"eighty":45.891374,"marketCap":5733120163},{"date":"2022-01-21","current":33.356681,"twenty":7.907699,"median":17.862859,"eighty":45.891374,"marketCap":5480002275},{"date":"2022-01-28","current":34.223338,"twenty":7.943549,"median":18.081923,"eighty":45.891374,"marketCap":5622381087},{"date":"2022-02-04","current":36.187761,"twenty":8.039903,"median":18.360975,"eighty":45.891374,"marketCap":5945106394},{"date":"2022-02-11","current":36.110725,"twenty":8.136529,"median":18.515656,"eighty":45.891374,"marketCap":5932450500},{"date":"2022-02-18","current":27.042003,"twenty":8.217909,"median":18.789229,"eighty":45.891374,"marketCap":6248406283},{"date":"2022-02-25","current":27.899162,"twenty":8.270506,"median":18.897922,"eighty":45.891374,"marketCap":6446464151},{"date":"2022-03-04","current":28.61807,"twenty":8.371042,"median":19.106053,"eighty":45.891374,"marketCap":6612577201},{"date":"2022-03-11","current":29.019,"twenty":8.507031,"median":19.335948,"eighty":45.891374,"marketCap":6705217172},{"date":"2022-03-18","current":29.572006,"twenty":8.621808,"median":21.199768,"eighty":45.891374,"marketCap":6832996441},{"date":"2022-03-25","current":30.249439,"twenty":8.73225,"median":22.506564,"eighty":45.891374,"marketCap":6989526047},{"date":"2022-04-01","current":31.645779,"twenty":8.756029,"median":22.697854,"eighty":45.891374,"marketCap":7312168702},{"date":"2022-04-08","current":31.825506,"twenty":8.792498,"median":22.852188,"eighty":45.891374,"marketCap":7353696965},{"date":"2022-04-14","current":31.995647,"twenty":8.865935,"median":22.952956,"eighty":45.891374,"marketCap":7393010230},{"date":"2022-04-22","current":31.067233,"twenty":8.939729,"median":23.213643,"eighty":45.891374,"marketCap":7178488062},{"date":"2022-04-29","current":30.956378,"twenty":8.974263,"median":23.420305,"eighty":45.891374,"marketCap":7152873475},{"date":"2022-05-06","current":29.778539,"twenty":9.039592,"median":23.531551,"eighty":45.891374,"marketCap":6880718486},{"date":"2022-05-13","current":21.60979,"twenty":9.09473,"median":23.549925,"eighty":45.891374,"marketCap":6440473677},{"date":"2022-05-20","current":19.113041,"twenty":9.107191,"median":23.549925,"eighty":45.891374,"marketCap":5696355204},{"date":"2022-05-27","current":19.801799,"twenty":9.125872,"median":23.549925,"eighty":45.891374,"marketCap":5901629266},{"date":"2022-06-03","current":20.490558,"twenty":9.145972,"median":23.549925,"eighty":45.891374,"marketCap":6106903327},{"date":"2022-06-10","current":19.521991,"twenty":9.183299,"median":23.549925,"eighty":45.891374,"marketCap":5818236678},{"date":"2022-06-17","current":19.973989,"twenty":9.197529,"median":23.549925,"eighty":45.891374,"marketCap":5952947781},{"date":"2022-06-24","current":23.912825,"twenty":9.237499,"median":23.564333,"eighty":45.919924,"marketCap":7126858820},{"date":"2022-07-01","current":23.213305,"twenty":9.247736,"median":23.584442,"eighty":45.919924,"marketCap":6918377351},{"date":"2022-07-08","current":23.686826,"twenty":9.281845,"median":23.611294,"eighty":45.919924,"marketCap":7059503269},{"date":"2022-07-15","current":22.965782,"twenty":9.328108,"median":23.611294,"eighty":45.919924,"marketCap":6844606986},{"date":"2022-07-22","current":22.449214,"twenty":9.353834,"median":23.633017,"eighty":45.919924,"marketCap":6690651440},{"date":"2022-07-29","current":22.513785,"twenty":9.38718,"median":23.633017,"eighty":45.919924,"marketCap":6709895883},{"date":"2022-08-05","current":23.159496,"twenty":9.423477,"median":23.633017,"eighty":45.919924,"marketCap":6902340315},{"date":"2022-08-12","current":22.996839,"twenty":9.477679,"median":23.677084,"eighty":45.919924,"marketCap":6269283152},{"date":"2022-08-19","current":22.819758,"twenty":9.532448,"median":23.677084,"eighty":45.919924,"marketCap":6221008384},{"date":"2022-08-26","current":21.521169,"twenty":9.589879,"median":23.677084,"eighty":45.919924,"marketCap":5866993422},{"date":"2022-09-02","current":21.143397,"twenty":9.637235,"median":23.677084,"eighty":45.919924,"marketCap":5764007251},{"date":"2022-09-09","current":21.131592,"twenty":9.656291,"median":23.677084,"eighty":45.919924,"marketCap":5760788933},{"date":"2022-09-16","current":20.24619,"twenty":9.709392,"median":23.677084,"eighty":45.919924,"marketCap":5519415095},{"date":"2022-09-23","current":19.219124,"twenty":9.737158,"median":23.677084,"eighty":45.919924,"marketCap":5239421443},{"date":"2022-09-30","current":18.510802,"twenty":9.752596,"median":23.677084,"eighty":45.919924,"marketCap":5046322373},{"date":"2022-10-07","current":18.180252,"twenty":9.809283,"median":23.677084,"eighty":45.919924,"marketCap":4956209473},{"date":"2022-10-14","current":18.475386,"twenty":9.839263,"median":23.677084,"eighty":45.919924,"marketCap":5036667419},{"date":"2022-10-21","current":19.419815,"twenty":9.921087,"median":23.677084,"eighty":45.919924,"marketCap":5294132846},{"date":"2022-10-28","current":19.632311,"twenty":9.95111,"median":23.677084,"eighty":45.919924,"marketCap":5352062567},{"date":"2022-11-04","current":17.259423,"twenty":9.977849,"median":23.677084,"eighty":45.919924,"marketCap":5309360940},{"date":"2022-11-11","current":17.615936,"twenty":10.045835,"median":23.677084,"eighty":45.919924,"marketCap":5419031822},{"date":"2022-11-18","current":17.731278,"twenty":10.09551,"median":23.677084,"eighty":45.919924,"marketCap":5454513578},{"date":"2022-11-25","current":17.762735,"twenty":10.137764,"median":23.677084,"eighty":45.919924,"marketCap":5464190420},{"date":"2022-12-02","current":18.234591,"twenty":10.262522,"median":23.677084,"eighty":45.919924,"marketCap":5609343059},{"date":"2022-12-09","current":16.535911,"twenty":10.306552,"median":23.677084,"eighty":45.919924,"marketCap":5086793561},{"date":"2022-12-16","current":16.714168,"twenty":10.501618,"median":23.677084,"eighty":45.919924,"marketCap":5141629002},{"date":"2022-12-23","current":16.598825,"twenty":10.590509,"median":23.677084,"eighty":45.919924,"marketCap":5106147246},{"date":"2022-12-30","current":16.819025,"twenty":10.667114,"median":23.677084,"eighty":45.919924,"marketCap":5173885144},{"date":"2023-01-06","current":18.108763,"twenty":10.667114,"median":23.584442,"eighty":45.49168,"marketCap":5570635688},{"date":"2023-01-13","current":17.227966,"twenty":10.667114,"median":23.503875,"eighty":45.1654,"marketCap":5299684097},{"date":"2023-01-20","current":17.542536,"twenty":10.667114,"median":23.449537,"eighty":44.010071,"marketCap":5396452523},{"date":"2023-01-27","current":18.318476,"twenty":10.667114,"median":23.314972,"eighty":43.020435,"marketCap":5635147972},{"date":"2023-02-03","current":18.402362,"twenty":10.667114,"median":23.194326,"eighty":42.458135,"marketCap":5660952885},{"date":"2023-02-10","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":42.011762,"marketCap":5687732764},{"date":"2023-02-17","current":31.096255,"twenty":10.667114,"median":23.191781,"eighty":41.420955,"marketCap":5668287524},{"date":"2023-02-24","current":30.456195,"twenty":10.667114,"median":23.191781,"eighty":41.184268,"marketCap":5551616082},{"date":"2023-03-03","current":30.491754,"twenty":10.667114,"median":23.191781,"eighty":40.984929,"marketCap":5558097829},{"date":"2023-03-10","current":29.65612,"twenty":10.667114,"median":23.191781,"eighty":40.686627,"marketCap":5405776781},{"date":"2023-03-17","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":40.243946,"marketCap":5687732764},{"date":"2023-03-24","current":32.85642,"twenty":10.667114,"median":23.191781,"eighty":39.955417,"marketCap":5989133987},{"date":"2023-03-31","current":34.509909,"twenty":10.667928,"median":23.193053,"eighty":39.475483,"marketCap":6290535211},{"date":"2023-04-06","current":35.363322,"twenty":10.667928,"median":23.193053,"eighty":39.271956,"marketCap":6446097132},{"date":"2023-04-14","current":34.918836,"twenty":10.667114,"median":23.191781,"eighty":39.023166,"marketCap":6365075298},{"date":"2023-04-21","current":33.620936,"twenty":10.667114,"median":23.191781,"eighty":38.427704,"marketCap":6128491542},{"date":"2023-04-28","current":32.305257,"twenty":10.667114,"median":23.191781,"eighty":37.395181,"marketCap":5888666913},{"date":"2023-05-05","current":34.73643,"twenty":10.667114,"median":23.191781,"eighty":37.193084,"marketCap":6331825854},{"date":"2023-05-12","current":40.911234,"twenty":10.667114,"median":23.213305,"eighty":37.526354,"marketCap":6289570343},{"date":"2023-05-19","current":41.790934,"twenty":10.666299,"median":23.203815,"eighty":38.431783,"marketCap":6424812840},{"date":"2023-05-26","current":40.308235,"twenty":10.666299,"median":23.203815,"eighty":39.03948,"marketCap":6196867124},{"date":"2023-05-31","current":40.265872,"twenty":10.666299,"median":23.203815,"eighty":39.188346,"marketCap":6190354389},{"date":"2023-06-09","current":40.98604,"twenty":10.659474,"median":23.193053,"eighty":39.394311,"marketCap":6301070880},{"date":"2023-06-16","current":40.456505,"twenty":10.636307,"median":23.23296,"eighty":39.77769,"marketCap":6219661695},{"date":"2023-06-22","current":40.265872,"twenty":10.614439,"median":23.277876,"eighty":40.236218,"marketCap":6190354389},{"date":"2023-06-26","current":42.066293,"twenty":10.603505,"median":23.311527,"eighty":40.265872,"marketCap":6467145616},{"date":"2023-07-07","current":40.943677,"twenty":10.600095,"median":23.213305,"eighty":40.520035,"marketCap":6294558145},{"date":"2023-07-14","current":40.98604,"twenty":10.600095,"median":23.213305,"eighty":40.545455,"marketCap":6301070880},{"date":"2023-07-21","current":42.087474,"twenty":10.600095,"median":23.213305,"eighty":40.680159,"marketCap":6470401984},{"date":"2023-07-28","current":41.515576,"twenty":10.600095,"median":23.213305,"eighty":40.924511,"marketCap":6382480064},{"date":"2023-08-04","current":40.24272,"twenty":10.600095,"median":23.354574,"eighty":40.932036,"marketCap":6609585096},{"date":"2023-08-11","current":40.998725,"twenty":10.600095,"median":23.481924,"eighty":40.941559,"marketCap":6733753602},{"date":"2023-08-18","current":40.707954,"twenty":10.600095,"median":23.579987,"eighty":40.983764,"marketCap":6685996485},{"date":"2023-08-25","current":42.161809,"twenty":10.600095,"median":23.703849,"eighty":41.024602,"marketCap":6924782073},{"date":"2023-09-01","current":43.402433,"twenty":10.600095,"median":23.784876,"eighty":41.205168,"marketCap":7128545776},{"date":"2023-09-08","current":42.685197,"twenty":10.600095,"median":23.881479,"eighty":41.417849,"marketCap":7010744885},{"date":"2023-09-15","current":43.169816,"twenty":10.600095,"median":23.959006,"eighty":41.704282,"marketCap":7090340081},{"date":"2023-09-22","current":41.832269,"twenty":10.600095,"median":24.063445,"eighty":41.742049,"marketCap":6870657340},{"date":"2023-09-29","current":43.402433,"twenty":10.600095,"median":24.159779,"eighty":41.859163,"marketCap":7128545776},{"date":"2023-10-06","current":42.917814,"twenty":10.600095,"median":24.411169,"eighty":41.925256,"marketCap":7048950579},{"date":"2023-10-13","current":41.173188,"twenty":10.600095,"median":24.472259,"eighty":41.970666,"marketCap":6762407873},{"date":"2023-10-20","current":40.378413,"twenty":10.600095,"median":24.601456,"eighty":42.032402,"marketCap":6631871751},{"date":"2023-10-27","current":40.688569,"twenty":10.590509,"median":24.763289,"eighty":42.053584,"marketCap":6682812677},{"date":"2023-11-03","current":67.987802,"twenty":10.590509,"median":24.82708,"eighty":42.104419,"marketCap":6259908894},{"date":"2023-11-10","current":70.993721,"twenty":10.590509,"median":24.916894,"eighty":42.169563,"marketCap":6536675855},{"date":"2023-11-17","current":70.858623,"twenty":10.590509,"median":25.114925,"eighty":42.251018,"marketCap":6524236890},{"date":"2023-11-24","current":73.222829,"twenty":10.590509,"median":25.234082,"eighty":42.431195,"marketCap":6741918769},{"date":"2023-12-01","current":73.661896,"twenty":10.590509,"median":25.380185,"eighty":42.822269,"marketCap":6782345404},{"date":"2023-12-08","current":74.269835,"twenty":10.594875,"median":25.475549,"eighty":42.99923,"marketCap":6838320744},{"date":"2023-12-15","current":78.728051,"twenty":10.594875,"median":25.683605,"eighty":43.169816,"marketCap":7248806574},{"date":"2023-12-22","current":79.302215,"twenty":10.594875,"median":25.809174,"eighty":43.432834,"marketCap":7301672173},{"date":"2023-12-29","current":81.497549,"twenty":10.590509,"median":25.871438,"eighty":43.801759,"marketCap":7503805346},{"date":"2024-01-05","current":79.741282,"twenty":10.586142,"median":26.026128,"eighty":45.173557,"marketCap":7342098807},{"date":"2024-01-12","current":75.688358,"twenty":10.586142,"median":26.123266,"eighty":45.499837,"marketCap":6968929872},{"date":"2024-01-19","current":75.215517,"twenty":10.581776,"median":26.310309,"eighty":46.429737,"marketCap":6925393496},{"date":"2024-01-26","current":74.607578,"twenty":10.586142,"median":26.757641,"eighty":47.070063,"marketCap":6869418156},{"date":"2024-02-02","current":73.45925,"twenty":10.586142,"median":26.8819,"eighty":48.970648,"marketCap":6763686957},{"date":"2024-02-09","current":29.434352,"twenty":10.586142,"median":27.133306,"eighty":50.736642,"marketCap":6115428204},{"date":"2024-02-16","current":30.047264,"twenty":10.666299,"median":27.737543,"eighty":50.736642,"marketCap":6242769792},{"date":"2024-02-23","current":30.222382,"twenty":10.755729,"median":28.081886,"eighty":50.736642,"marketCap":6279153103},{"date":"2024-03-01","current":31.958965,"twenty":12.580654,"median":28.465994,"eighty":50.389968,"marketCap":6639954272},{"date":"2024-03-08","current":32.236234,"twenty":14.477572,"median":28.687196,"eighty":50.389968,"marketCap":6697561181},{"date":"2024-03-15","current":32.995077,"twenty":15.693391,"median":29.087177,"eighty":50.389968,"marketCap":6855222195},{"date":"2024-03-22","current":34.906778,"twenty":16.21505,"median":29.378454,"eighty":50.389968,"marketCap":7252406675},{"date":"2024-03-28","current":34.819219,"twenty":16.431775,"median":29.448945,"eighty":50.389968,"marketCap":7234215019},{"date":"2024-04-05","current":34.279273,"twenty":16.579951,"median":29.605173,"eighty":50.736642,"marketCap":7122033143},{"date":"2024-04-12","current":33.05345,"twenty":16.813772,"median":29.772048,"eighty":50.736642,"marketCap":6867349966},{"date":"2024-04-19","current":31.911299,"twenty":16.916749,"median":30.058488,"eighty":50.736642,"marketCap":6630050987},{"date":"2024-04-26","current":33.386966,"twenty":17.091652,"median":30.249439,"eighty":50.389968,"marketCap":6936642941},{"date":"2024-05-03","current":31.422916,"twenty":17.176551,"median":30.506341,"eighty":50.389968,"marketCap":6443394612},{"date":"2024-05-10","current":30.911512,"twenty":17.328629,"median":30.882901,"eighty":50.389968,"marketCap":6338529239},{"date":"2024-05-17","current":30.158612,"twenty":17.488992,"median":30.882901,"eighty":50.389968,"marketCap":6184144105},{"date":"2024-05-24","current":28.993748,"twenty":17.580284,"median":30.882901,"eighty":50.389968,"marketCap":5945284088},{"date":"2024-05-31","current":30.812073,"twenty":17.615936,"median":30.882901,"eighty":50.389968,"marketCap":6318138749},{"date":"2024-06-07","current":31.08198,"twenty":17.668364,"median":30.954522,"eighty":50.389968,"marketCap":6373484363},{"date":"2024-06-14","current":30.883101,"twenty":17.731278,"median":31.025137,"eighty":50.389968,"marketCap":6332703384},{"date":"2024-06-21","current":31.536561,"twenty":17.769898,"median":31.042917,"eighty":50.736642,"marketCap":6466698028},{"date":"2024-06-28","current":31.920114,"twenty":17.8613,"median":31.103323,"eighty":50.736642,"marketCap":6545347058},{"date":"2024-07-05","current":31.394505,"twenty":18.024877,"median":31.149457,"eighty":50.736642,"marketCap":6437568758},{"date":"2024-07-12","current":31.820674,"twenty":18.175107,"median":31.199278,"eighty":50.736642,"marketCap":6524956569},{"date":"2024-07-19","current":32.104788,"twenty":18.272126,"median":31.292005,"eighty":50.736642,"marketCap":6583215110},{"date":"2024-07-26","current":33.227035,"twenty":18.414252,"median":31.360962,"eighty":50.736642,"marketCap":6813336346},{"date":"2024-08-02","current":34.335076,"twenty":18.480333,"median":31.430019,"eighty":50.736642,"marketCap":7040544655},{"date":"2024-08-09","current":21.981185,"twenty":18.723299,"median":31.444483,"eighty":50.736642,"marketCap":7693239023},{"date":"2024-08-16","current":21.475871,"twenty":18.914042,"median":31.444483,"eighty":50.736642,"marketCap":7516382953},{"date":"2024-08-23","current":21.09281,"twenty":19.069994,"median":31.444483,"eighty":50.736642,"marketCap":7382314643},{"date":"2024-08-30","current":21.215063,"twenty":19.173593,"median":31.444483,"eighty":50.736642,"marketCap":7425102401},{"date":"2024-09-06","current":20.497842,"twenty":19.271067,"median":31.444483,"eighty":50.736642,"marketCap":7174080883},{"date":"2024-09-13","current":21.565523,"twenty":19.391482,"median":31.444483,"eighty":50.736642,"marketCap":7547760643},{"date":"2024-09-20","current":21.532922,"twenty":19.566201,"median":31.444483,"eighty":50.736642,"marketCap":7536350574},{"date":"2024-09-27","current":21.158012,"twenty":19.756599,"median":31.444483,"eighty":50.736642,"marketCap":7405134781},{"date":"2024-10-04","current":21.728528,"twenty":20.051881,"median":31.444483,"eighty":50.736642,"marketCap":7604810988},{"date":"2024-10-11","current":21.378068,"twenty":20.260356,"median":31.444483,"eighty":50.736642,"marketCap":7482152746},{"date":"2024-10-18","current":23.554181,"twenty":20.577253,"median":31.444483,"eighty":50.736642,"marketCap":8243774852},{"date":"2024-10-25","current":22.714707,"twenty":20.830566,"median":31.444483,"eighty":50.736642,"marketCap":7949965575},{"date":"2024-11-01","current":20.868399,"twenty":20.870141,"median":31.444483,"eighty":50.736642,"marketCap":9743956162},{"date":"2024-11-08","current":22.171145,"twenty":20.970556,"median":31.444483,"eighty":50.736642,"marketCap":10352239475},{"date":"2024-11-15","current":21.070232,"twenty":21.016922,"median":31.444483,"eighty":50.736642,"marketCap":9838197239},{"date":"2024-11-22","current":21.779709,"twenty":21.079263,"median":31.444483,"eighty":50.736642,"marketCap":10169468902},{"date":"2024-11-29","current":22.299584,"twenty":21.136314,"median":31.444483,"eighty":50.736642,"marketCap":10412211069},{"date":"2024-12-06","current":21.908149,"twenty":21.209839,"median":31.444483,"eighty":50.736642,"marketCap":10229440496},{"date":"2024-12-13","current":21.424971,"twenty":21.270039,"median":31.444483,"eighty":50.736642,"marketCap":10003833070},{"date":"2024-12-20","current":20.360756,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9506925575},{"date":"2024-12-27","current":20.678797,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9655426666},{"date":"2025-01-03","current":20.776656,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9701119309},{"date":"2025-01-10","current":22.030472,"twenty":21.317067,"median":31.451844,"eighty":51.083315,"marketCap":10286556300},{"date":"2025-01-17","current":22.140564,"twenty":21.392738,"median":31.451844,"eighty":51.083315,"marketCap":10337960524},{"date":"2025-01-24","current":19.804184,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9247048667},{"date":"2025-01-31","current":20.275129,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9466944513},{"date":"2025-02-07","current":20.476963,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9561185589},{"date":"2025-02-14","current":18.792386,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9795850750},{"date":"2025-02-21","current":19.785698,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10313631432},{"date":"2025-02-28","current":20.773641,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10828613300},{"date":"2025-03-07","current":20.714579,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10797826341},{"date":"2025-03-14","current":19.678313,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10257655142},{"date":"2025-03-21","current":19.84476,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10344418392},{"date":"2025-03-28","current":19.705159,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10271649215},{"date":"2025-04-04","current":18.561508,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":9675501726},{"date":"2025-04-11","current":18.958833,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9882613999},{"date":"2025-04-17","current":19.324707,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10073332113},{"date":"2025-04-25","current":19.986841,"twenty":21.378068,"median":31.451844,"eighty":51.429988,"marketCap":10418480823},{"date":"2025-05-02","current":21.145576,"twenty":21.26595,"median":31.451844,"eighty":51.429988,"marketCap":11022491066},{"date":"2025-05-09","current":19.314028,"twenty":21.215063,"median":31.451844,"eighty":51.429988,"marketCap":10067765198},{"date":"2025-05-16","current":19.238052,"twenty":21.149861,"median":31.451844,"eighty":51.429988,"marketCap":12380955912},{"date":"2025-05-23","current":18.161738,"twenty":21.100813,"median":31.451844,"eighty":51.429988,"marketCap":11688276880},{"date":"2025-05-30","current":18.051564,"twenty":21.052058,"median":31.451844,"eighty":51.429988,"marketCap":11617372728},{"date":"2025-06-06","current":17.954102,"twenty":21.011307,"median":31.451844,"eighty":51.429988,"marketCap":11554649823},{"date":"2025-06-13","current":17.704092,"twenty":20.970556,"median":31.451844,"eighty":51.429988,"marketCap":11393751938},{"date":"2025-06-20","current":17.263397,"twenty":20.919812,"median":31.451844,"eighty":52.534404,"marketCap":11110135327},{"date":"2025-06-27","current":18.259199,"twenty":20.836957,"median":31.451844,"eighty":52.534404,"marketCap":11750999785},{"date":"2025-07-03","current":19.555861,"twenty":20.776053,"median":31.451844,"eighty":52.534404,"marketCap":12585487122},{"date":"2025-07-11","current":19.14059,"twenty":20.723755,"median":31.451844,"eighty":52.534404,"marketCap":12318233007},{"date":"2025-07-18","current":19.013466,"twenty":20.683176,"median":31.451844,"eighty":52.534404,"marketCap":12236420523},{"date":"2025-07-25","current":18.979567,"twenty":20.586623,"median":31.451844,"eighty":52.534404,"marketCap":12214603861},{"date":"2025-08-01","current":16.188856,"twenty":20.513914,"median":31.451844,"eighty":52.534404,"marketCap":9750515310},{"date":"2025-08-08","current":16.711798,"twenty":20.476963,"median":31.451844,"eighty":52.534404,"marketCap":10065482260},{"date":"2025-08-15","current":17.194513,"twenty":20.30571,"median":31.451844,"eighty":52.534404,"marketCap":10356220982},{"date":"2025-08-22","current":17.301783,"twenty":20.251749,"median":31.451844,"eighty":52.534404,"marketCap":10420829587},{"date":"2025-08-29","current":16.939747,"twenty":20.21434,"median":31.451844,"eighty":52.534404,"marketCap":10202775545},{"date":"2025-09-05","current":16.707328,"twenty":20.146713,"median":31.458689,"eighty":53.63882,"marketCap":10062790234},{"date":"2025-09-12","current":17.462689,"twenty":19.984406,"median":31.451844,"eighty":52.534404,"marketCap":10517742495},{"date":"2025-09-19","current":18.079492,"twenty":19.948593,"median":31.451844,"eighty":52.534404,"marketCap":10889241974},{"date":"2025-09-26","current":17.292844,"twenty":19.877101,"median":31.451844,"eighty":52.534404,"marketCap":10415445537},{"date":"2025-10-03","current":18.481755,"twenty":19.840807,"median":31.451844,"eighty":52.534404,"marketCap":11131524243},{"date":"2025-10-10","current":17.239209,"twenty":19.803707,"median":31.451844,"eighty":52.534404,"marketCap":10383141234},{"date":"2025-10-17","current":17.525263,"twenty":19.742534,"median":31.451844,"eighty":52.534404,"marketCap":10555430848},{"date":"2025-10-24","current":17.006791,"twenty":19.679289,"median":31.451844,"eighty":52.534404,"marketCap":10243155924},{"date":"2025-10-31","current":17.404584,"twenty":19.615895,"median":31.451844,"eighty":52.534404,"marketCap":10482746167},{"date":"2025-11-07","current":16.202116,"twenty":19.555861,"median":31.437122,"eighty":52.534404,"marketCap":10983462856},{"date":"2025-11-14","current":16.817637,"twenty":19.509455,"median":31.380299,"eighty":52.534404,"marketCap":11400726764},{"date":"2025-11-21","current":16.591284,"twenty":19.373439,"median":31.295065,"eighty":52.534404,"marketCap":11247281327},{"date":"2025-11-28","current":17.540379,"twenty":19.314266,"median":31.202932,"eighty":52.534404,"marketCap":11890675352},{"date":"2025-12-05","current":17.619801,"twenty":19.287595,"median":31.161149,"eighty":52.534404,"marketCap":11944515856},{"date":"2025-12-12","current":16.436411,"twenty":19.234266,"median":31.110391,"eighty":52.534404,"marketCap":11142292344},{"date":"2025-12-19","current":16.905002,"twenty":19.13508,"median":31.060696,"eighty":52.534404,"marketCap":11459951318},{"date":"2025-12-26","current":18.469618,"twenty":19.091517,"median":30.989578,"eighty":52.534404,"marketCap":12520609251},{"date":"2026-01-02","current":17.405361,"twenty":19.012619,"median":30.926871,"eighty":52.534404,"marketCap":11799146495},{"date":"2026-01-09","current":17.532437,"twenty":18.97458,"median":30.882901,"eighty":52.534404,"marketCap":11885291302},{"date":"2026-01-16","current":18.044709,"twenty":18.899845,"median":30.670016,"eighty":50.234126,"marketCap":12232562554},{"date":"2026-01-23","current":17.671425,"twenty":18.838561,"median":30.491754,"eighty":50.234126,"marketCap":11979512184},{"date":"2026-01-30","current":16.78984,"twenty":18.766673,"median":30.249439,"eighty":50.234126,"marketCap":11381882587},{"date":"2026-02-06","current":16.825579,"twenty":18.695068,"median":30.105636,"eighty":50.234126,"marketCap":11406110814},{"date":"2026-02-13","current":14.170695,"twenty":18.554438,"median":29.889985,"eighty":43.40631,"marketCap":11089561020},{"date":"2026-02-20","current":14.65522,"twenty":18.504467,"median":29.831882,"eighty":43.092277,"marketCap":11468735706},{"date":"2026-02-27","current":14.695044,"twenty":18.475686,"median":29.755401,"eighty":42.964338,"marketCap":11499900748},{"date":"2026-03-06","current":13.699445,"twenty":18.456655,"median":29.521911,"eighty":42.638674,"marketCap":10720774681},{"date":"2026-03-13","current":13.66294,"twenty":18.41075,"median":29.44758,"eighty":42.285872,"marketCap":10692206726},{"date":"2026-03-16","current":13.68617,"twenty":18.397459,"median":29.434352,"eighty":42.231595,"marketCap":10710386334}],"updateTime":1773742264462},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EXEL\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1123873342","title":"Earning Preview: Exelixis Q4 revenue is expected to increase by 7.19%, and institutional views are mostly positive","url":"https://stock-news.laohu8.com/highlight/detail?id=1123873342","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123873342?lang=en_us&edition=fundamental","pubTime":"2026-02-03 11:40","pubTimestamp":1770090020,"startTime":"0","endTime":"0","summary":"AbstractExelixis will report its Q4 2025 results on February 10, 2026 Post Market; this preview consolidates company guidance, last quarter performance, and recent institutional views to frame...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Exelixis Q4 revenue is expected to increase by 7.19%, and institutional views are mostly positive","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"gpt_icon":0},{"id":"2608895956","title":"Exelixis Is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2608895956","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608895956?lang=en_us&edition=fundamental","pubTime":"2026-02-03 00:27","pubTimestamp":1770049620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EXEL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 02, 2026 11:27 ET (16:27 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4139","BK4532"],"gpt_icon":0},{"id":"2608864888","title":"Exelixis reports zanzalintinib new drug application accepted for review by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2608864888","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608864888?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:17","pubTimestamp":1770038224,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) announced that its new drug application for zanzalintinib, in combination with atezolizumab, has been accepted for review in the U....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-reports-zanzalintinib-new-drug-application-accepted-for-review-by-fda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-reports-zanzalintinib-new-drug-application-accepted-for-review-by-fda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4139","EXEL"],"gpt_icon":0},{"id":"2608861861","title":"FDA Accepts Exelixis Application for Zanzalintinib Combination in Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2608861861","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608861861?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:01","pubTimestamp":1770037261,"startTime":"0","endTime":"0","summary":"Exelixis Inc. announced that the U.S. Food and Drug Administration  has accepted its New Drug Application  for zanzalintinib in combination with atezolizumab  for the treatment of adult patients with metastatic colorectal cancer who have previously received standard chemotherapy and, if RAS wild-type, an anti-EGFR therapy. The application is supported by results from the phase 3 STELLAR-303 trial, which showed a statistically significant improvement in overall survival compared to regorafenib. The FDA has assigned a Prescription Drug User Fee Act  target action date of December 3, 2026. The final analysis of the trial's secondary endpoint is expected in mid-2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDLbMwZY6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EXEL","BK4532"],"gpt_icon":0},{"id":"2608869045","title":"Exelixis Inc - FDA Sets Pdufa Target Action Date for December 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2608869045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608869045?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:00","pubTimestamp":1770037203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA5DGKSS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4139","EXEL"],"gpt_icon":0},{"id":"2608869044","title":"Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination With an Immune Checkpoint Inhibitor for Patients With Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2608869044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608869044?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:00","pubTimestamp":1770037203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA5DGKSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXEL","BK4139","BK4532"],"gpt_icon":0},{"id":"2608286599","title":"Morgan Stanley Lifts Price Target on Exelixis to $49 From $48, Keeps Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2608286599","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608286599?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:57","pubTimestamp":1770033476,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) has an average rating of overweight and mean price target of $45.78, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXEL"],"gpt_icon":0},{"id":"2606758579","title":"Exelixis Inc. to Release Fourth Quarter and Fiscal Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2606758579","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606758579?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:05","pubTimestamp":1769547918,"startTime":"0","endTime":"0","summary":"Exelixis Inc. will release its fourth quarter and fiscal year 2025 financial results on Tuesday, February 10, 2026, after the markets close. Company management will host a conference call and webcast to discuss the results and provide a business update at 5:00 p.m. ET / 2:00 p.m. PT. Results will be released on the company's website. Access to the webcast is available via the www.exelixis.com Event Calendar page under the Investors & News heading. To access the conference call, participants must register to receive a dial-in number and PIN. A webcast replay will be archived on the company's website for one year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL3GxTQQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","EXEL"],"gpt_icon":0},{"id":"2606778599","title":"Exelixis Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2606778599","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606778599?lang=en_us&edition=fundamental","pubTime":"2026-01-27 19:24","pubTimestamp":1769513040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EXEL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 27, 2026 06:24 ET (11:24 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"gpt_icon":0},{"id":"2606878562","title":"Exelixis price target raised to $52 from $49 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2606878562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606878562?lang=en_us&edition=fundamental","pubTime":"2026-01-27 19:10","pubTimestamp":1769512252,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Exelixis (EXEL) to $52 from $49 and keeps a Buy rating on the shares. The company issued “encoura...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-price-target-raised-to-52-from-49-at-h-c-wainwright-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-price-target-raised-to-52-from-49-at-h-c-wainwright-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL"],"gpt_icon":0},{"id":"2604992934","title":"Assessing Exelixis (EXEL) Valuation After Recent Share Price Pullback And Long Term Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2604992934","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604992934?lang=en_us&edition=fundamental","pubTime":"2026-01-18 04:28","pubTimestamp":1768681714,"startTime":"0","endTime":"0","summary":"Why Exelixis (EXEL) Is On Investors’ Radar Today\nExelixis (EXEL) has drawn attention after recent trading left the shares at a last close of US$43.96, prompting investors to reassess the oncology company’s profile and the value they place on its pipeline.\nSee our latest analysis for Exelixis.\nDespite a 3.26% 1 day share price decline and a flat week, Exelixis has a 4.67% 30 day share price return and a 21.44% 1 year total shareholder return, while the 3 year total shareholder return of...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/assessing-exelixis-exel-valuation-after-recent-share-price-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/assessing-exelixis-exel-valuation-after-recent-share-price-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4532","EXEL"],"gpt_icon":0},{"id":"2603611891","title":"Truist Securities Adjusts Price Target on Exelixis to $51 From $49, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2603611891","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603611891?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:47","pubTimestamp":1768398472,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) has an average rating of overweight and mean price target of $45.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXEL"],"gpt_icon":0},{"id":"2603103566","title":"Does Exelixis’ 2026 Revenue Guidance and Zanzalintinib Push Change The Bull Case For EXEL?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603103566","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603103566?lang=en_us&edition=fundamental","pubTime":"2026-01-14 20:25","pubTimestamp":1768393532,"startTime":"0","endTime":"0","summary":"Exelixis recently released preliminary 2025 results, projecting total revenues of about US$2.32 billion and net product revenues of about US$2.12 billion, while guiding 2026 total revenues to US$2.53–2.63 billion and net product revenues to US$2.33–2.43 billion, alongside updates on its oncology pipeline and business.\nAt the same time, Exelixis moved to expand beyond cabozantinib by advancing zanzalintinib toward a potential first commercial indication and launching a new colorectal cancer...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/does-exelixis-2026-revenue-guidance-and-zanzalintinib-push-c","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/does-exelixis-2026-revenue-guidance-and-zanzalintinib-push-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EXEL"],"gpt_icon":0},{"id":"2603264655","title":"Exelixis Projects 2026 Net Product Revenues of $2.325 Billion to $2.425 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2603264655","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603264655?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:23","pubTimestamp":1768252997,"startTime":"0","endTime":"0","summary":"Exelixis Inc. announced preliminary unaudited financial results for fiscal year 2025, reporting approximately $2.123 billion in U.S. net product revenues from its cabozantinib franchise. For fiscal year 2026, the company issued financial guidance projecting net product revenues in the range of $2.325 billion to $2.425 billion. This outlook reflects a significant anticipated increase in business performance compared to the prior year, as Exelixis continues to grow its cabozantinib business and prepares for the potential launch of a second oncology franchise with zanzalintinib.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gather","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDLbxcyRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","EXEL"],"gpt_icon":0},{"id":"2602510058","title":"Exelixis, Citigroup And Other Big Stocks Moving Lower In Monday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510058","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510058?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":"U.S. stock futures were lower this morning, with the Dow futures falling more than 300 points on Monday.Shares of Exelixis Inc  fell sharply in pre-market trading after the company announced preliminary fiscal year 2025 financial results.Exelixis reported preliminary 2025 US net product revenue of $2.123 billion. The company also said it sees 2026 net product revenue of $2.325 billion to $2.425 billion.Exelixis shares dipped 4.6% to $42.01 in pre-market trading.Here are some other stocks moving lower in pre-market trading.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/12/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/12/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/01/49840621/exelixis-citigroup-and-other-big-stocks-moving-lower-in-mondays-pre-market-session","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/01/49840621/exelixis-citigroup-and-other-big-stocks-moving-lower-in-mondays-pre-market-session","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","BK4532","EXEL"],"gpt_icon":0},{"id":"2602515003","title":"Press Release: Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602515003","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602515003?lang=en_us&edition=fundamental","pubTime":"2026-01-12 18:37","pubTimestamp":1768214220,"startTime":"0","endTime":"0","summary":"-- Cabozantinib franchise achieves approximately $2.123 billion in preliminary U.S. net product revenues for fiscal year 2025 --. -- Fiscal year 2026 net product revenues guidance of $2.325 billion - $2.425 billion --. -- Presentation and webcast at J.P. Morgan 2026 Healthcare Conference tomorrow, Monday, January 12 at 5:15 p.m. PT / 8:15 p.m. ET --. Exelixis, Inc.  today announced its preliminary unaudited financial results for the fiscal year 2025, provided financial guidance for fiscal year 2026 and delivered an update on its business. Exelixis anticipates 2026 will be a significant year of clinical, regulatory and commercial progress as the company grows its current cabozantinib business, works toward building a potential second commercial franchise with zanzalintinib and moves its earlier stage pipeline forward. As outlined at its December 2025 R&D Day, the company seeks to leverage its diverse pipeline and key clinical collaborations to build next-generation oncology franchises t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","R","BK4548","BK4195","BK4607","PFS","BK4554","BK4139","BK4560","BK4213","LU2065169927.USD","CRC","EXEL","LU2286300806.USD","BK4232","LU0266512127.USD","BK4588","RCC","NET","BK4211","BK4116","LU2065170008.USD","BK4022","LU2065171311.SGD","BK4097","BK4532","BK4585","ORR","OS","LU0456854461.SGD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2602590789","title":"Barclays Remains a Hold on Exelixis (EXEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602590789","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602590789?lang=en_us&edition=fundamental","pubTime":"2026-01-12 17:17","pubTimestamp":1768209479,"startTime":"0","endTime":"0","summary":"In a report released today, Etzer Darout from Barclays maintained a Hold rating on Exelixis, with a price target of $41.00. According to TipRanks, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-hold-on-exelixis-exel-blurbs-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-hold-on-exelixis-exel-blurbs-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4532","EXEL"],"gpt_icon":0},{"id":"2602593563","title":"Exelixis reports preliminary FY25 revenue $2.32B, consensus $2.33B","url":"https://stock-news.laohu8.com/highlight/detail?id=2602593563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602593563?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:20","pubTimestamp":1768170026,"startTime":"0","endTime":"0","summary":"“Exelixis (EXEL) enters 2026 with a strong and growing commercial business, the opportunity to bring a potential second oncology franchise to marke...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-reports-preliminary-fy25-revenue-2-32b-consensus-2-33b-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-reports-preliminary-fy25-revenue-2-32b-consensus-2-33b-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL"],"gpt_icon":0},{"id":"2602563590","title":"Exelixis sees FY26 revenue $2.525B-$2.625B, consensus $2.62B","url":"https://stock-news.laohu8.com/highlight/detail?id=2602563590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602563590?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:20","pubTimestamp":1768170016,"startTime":"0","endTime":"0","summary":"Michael Morrissey, Ph.D., President & CEO, Exelixis (EXEL) said, “To achieve our goal of becoming a top-5 solid tumor oncology company, Exelixis is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-sees-fy26-revenue-2-525b-2-625b-consensus-2-62b-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-sees-fy26-revenue-2-525b-2-625b-consensus-2-62b-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL"],"gpt_icon":0},{"id":"2602568344","title":"BRIEF-Exelixis Says Fiscal Year 2026 Net Product Revenues Guidance Of $2.325 Billion - $2.425 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568344","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568344?lang=en_us&edition=fundamental","pubTime":"2026-01-12 05:04","pubTimestamp":1768165444,"startTime":"0","endTime":"0","summary":"BRIEF-Exelixis Says Fiscal Year 2026 Net Product Revenues Guidance Of $2.325 Billion - $2.425 BillionJan 11 (Reuters) - Exelixis Inc EXEL.O:EXELIXIS ANNOUNCES PRELIMINARY FISCAL YEAR 2025 FINANCIAL RE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nTUA8BPWKW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","EXEL"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":3,"totalSize":162,"code":"91000000","status":"200"}]}}